Characteristics of Diabetic Foot Ulcer Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorGolestan University of Medical sciences
About this trial
This study examines the demographic, clinical, and laboratory characteristics of patients with diabetic foot ulcers admitted to 5 Azar Hospital, Gorgan, in 2024. By analyzing factors such as Hb, WBC, HbA1C, ESR, and CRP in relation to ulcer severity, the study aims to identify predictors of outcomes and support more effective prevention and management strategies
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients admitted to 5 Azar Hospital, Gorgan, in 2024
Diagnosis of diabetic foot ulcer (DFU) confirmed by medical records
Complete demographic, clinical, and laboratory data available in medical files
Disqualifiers
Incomplete or missing medical records
Patients with foot ulcers of non-diabetic etiology
Patients whose key laboratory data are unavailable
Trial population
The study population will consist of approximately 200 patients with diabetic foot ulcers admitted to 5 Azar Hospital, Gorgan, during 2024. Patients will be identified retrospectively from hospital medical records. Both demographic and clinical data, as well as laboratory findings, will be extracted for analysis
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Severity of diabetic foot ulcer (measured by Wagner classification at admission)
Measured by Wagner classification
Time frame
Baseline2
Laboratory parameters and ulcer grade
Association between Hb, WBC, HbA1C, ESR, and CRP levels with Wagner ulcer grade
Time frame
BaselineSecondary outcomes
1
Duration of diabetes until ulcer onset
Time (in years) between diabetes diagnosis and first DFU occurrence
Time frame
Baseline2
Smoking status and ulcer severity
Correlation between smoking history (yes/no) and Wagner ulcer grade
Time frame
Baseline3
Treatment outcomes
Frequency of outcomes: antibiotic therapy, wound debridement, or amputation
Time frame
At hospital discharge (average of 10 days)4
Ulcer recurrence
Number of hospital readmissions due to DFU.
Time frame
During 12-month follow-up (based on records)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov